These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 2045296

  • 21. Recipients of HLA-identical sibling marrow transplants with severe aplastic anemia engraft more quickly, and those with chronic myeloid leukemia more slowly, than those with acute leukemia.
    Atkinson K, Downs K, Ashby M, Dodds A, Concannon A, Biggs J.
    Bone Marrow Transplant; 1989 Jan; 4(1):23-7. PubMed ID: 2647183
    [Abstract] [Full Text] [Related]

  • 22. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
    Socié G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C, Cahn JY, Passweg JR, Rowlings PA, Schouten HC, Kolb HJ, Klein JP.
    N Engl J Med; 1999 Jul 01; 341(1):14-21. PubMed ID: 10387937
    [Abstract] [Full Text] [Related]

  • 23. Growth in children following irradiation for bone marrow transplantation.
    Bushhouse S, Ramsay NK, Pescovitz OH, Kim T, Robison LL.
    Am J Pediatr Hematol Oncol; 1989 Jul 01; 11(2):134-40. PubMed ID: 2665547
    [Abstract] [Full Text] [Related]

  • 24. Interstitial pneumonitis after allogeneic bone marrow transplantation following total body irradiation.
    Kurisu K, Taniguchi M, Kamikonya N, Hishikawa Y, Miura T, Inoue N, Kanamaru A, Kakishita E, Kai S, Hara H.
    Radiat Med; 1991 Jul 01; 9(3):118-21. PubMed ID: 1656487
    [Abstract] [Full Text] [Related]

  • 25. Preliminary experience with allogeneic bone marrow transplantation in haematological disorders in India.
    Saikia TK, Advani SH, Gopal R, Nair CN, Dinsha KA, Kurkure PA, Swaroop VS, Jagannath P, Sharma S, Rao RS.
    J Assoc Physicians India; 1990 May 01; 38(5):332-4. PubMed ID: 2387813
    [Abstract] [Full Text] [Related]

  • 26. Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study.
    Petersen FB, Buckner CD, Appelbaum FR, Sanders JE, Bensinger WI, Storb R, Deeg HJ, Witherspoon RP, Sullivan KM, Clift RA.
    Bone Marrow Transplant; 1992 Jul 01; 10(1):83-8. PubMed ID: 1515884
    [Abstract] [Full Text] [Related]

  • 27. Allogeneic bone marrow transplantation for adult acute lymphoblastic leukemia in first complete remission: factors predictive of transplant-related mortality and influence of total body irradiation modalities.
    Sutton L, Kuentz M, Cordonnier C, Blaise D, Devergie A, Guyotat D, Leblond V, Flesch M, Bordigoni P, Attal M.
    Bone Marrow Transplant; 1993 Dec 01; 12(6):583-9. PubMed ID: 8136742
    [Abstract] [Full Text] [Related]

  • 28. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
    Huss R, Deeg HJ, Gooley T, Bryant E, Leisenring W, Clift R, Buckner CD, Martin P, Storb R, Appelbaum FR.
    Bone Marrow Transplant; 1996 Oct 01; 18(4):767-76. PubMed ID: 8899193
    [Abstract] [Full Text] [Related]

  • 29. Effect of radiation dose on the development of mixed haemopoietic chimerism following T cell-depleted allogeneic bone marrow transplantation.
    Chalmers EA, Sproul AM, Mills KI, Stewart J, McNee S, Jones R, Barrett A, Simpson E, Gibson BE, Robertson AG.
    Bone Marrow Transplant; 1992 Nov 01; 10(5):425-30. PubMed ID: 1464004
    [Abstract] [Full Text] [Related]

  • 30. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
    Aschan J, Ringdén O.
    Clin Transplant; 1994 Jun 01; 8(3 Pt 1):258-70. PubMed ID: 8061365
    [Abstract] [Full Text] [Related]

  • 31. Prospective evaluation of pulmonary function in cancer patients treated with total body irradiation, high-dose melphalan, and autologous hematopoietic stem cell transplantation.
    Gandola L, Siena S, Bregni M, Sverzellati E, Piotti P, Stucchi C, Gianni AM, Lombardi F.
    Int J Radiat Oncol Biol Phys; 1990 Sep 01; 19(3):743-9. PubMed ID: 1976614
    [Abstract] [Full Text] [Related]

  • 32. Long-term complications of total body irradiation in adults.
    Thomas O, Mahé M, Campion L, Bourdin S, Milpied N, Brunet G, Lisbona A, Le Mevel A, Moreau P, Harousseau J, Cuillière J.
    Int J Radiat Oncol Biol Phys; 2001 Jan 01; 49(1):125-31. PubMed ID: 11163505
    [Abstract] [Full Text] [Related]

  • 33. Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens.
    Radich JP, Sanders JE, Buckner CD, Martin PJ, Petersen FB, Bensinger W, McDonald GB, Mori M, Schoch G, Hansen JA.
    J Clin Oncol; 1993 Feb 01; 11(2):304-13. PubMed ID: 8426208
    [Abstract] [Full Text] [Related]

  • 34. Pulmonary function changes in long-term survivors of chronic myelogenous leukemia after allogeneic bone marrow transplantation: a Taiwan experience.
    Chiou TJ, Tung SL, Wang WS, Tzeng WF, Yen CC, Fan FS, Liu JH, Chen PM.
    Cancer Invest; 2002 Feb 01; 20(7-8):880-8. PubMed ID: 12449718
    [Abstract] [Full Text] [Related]

  • 35. Long-term salivary function after conditioning with busulfan, fractionated or single-dose TBI.
    Garming-Legert K, Remberger M, Ringdén O, Hassan M, Dahllöf G.
    Oral Dis; 2011 Oct 01; 17(7):670-6. PubMed ID: 21718391
    [Abstract] [Full Text] [Related]

  • 36. Individual physician practice variation in hematopoietic cell transplantation.
    Lee SJ, Joffe S, Artz AS, Champlin RE, Davies SM, Jagasia M, Kernan NA, Loberiza FR, Soiffer RJ, Eapen M.
    J Clin Oncol; 2008 May 01; 26(13):2162-70. PubMed ID: 18378566
    [Abstract] [Full Text] [Related]

  • 37. Cataracts after bone marrow transplantation: long-term follow-up of adults treated with fractionated total body irradiation.
    Benyunes MC, Sullivan KM, Deeg HJ, Mori M, Meyer W, Fisher L, Bensinger R, Jack MK, Hicks J, Witherspoon R.
    Int J Radiat Oncol Biol Phys; 1995 Jun 15; 32(3):661-70. PubMed ID: 7790252
    [Abstract] [Full Text] [Related]

  • 38. Second allogeneic bone marrow transplantation after myeloablative conditioning analysis of 43 cases from single institution.
    Al-Qurashi F, Ayas M, Al Sharif F, Ibrahim E, Sahovic E, Al Mahr M, Chaudhri N, Al Mohareb F, Al Zahrani H, Al Jefri A, Al Omar H, Al Shanqeeti A, Seth P, Aslam M, El Solh H, Aljurf M.
    Hematology; 2004 Apr 15; 9(2):123-9. PubMed ID: 15203867
    [Abstract] [Full Text] [Related]

  • 39. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group.
    Phillips GL, Barnett MJ, Brain MC, Chan KW, Huebsch LB, Klingemann HG, Meharchand J, Reece DE, Rybka WB, Shepherd JD.
    Bone Marrow Transplant; 1991 Dec 15; 8(6):477-87. PubMed ID: 1790428
    [Abstract] [Full Text] [Related]

  • 40. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
    Wu DP, Milpied N, Moreau P, Mechinaud-Lacroix F, Mahe B, Le Tortorec S, Rapp MJ, Bourdin S, Mahe JM, Harousseau JL.
    Bone Marrow Transplant; 1994 Nov 15; 14(5):751-7. PubMed ID: 7889008
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.